Obesity in haemophilia patients: Effect on bleeding frequency, clotting factor concentrate usage, and haemostatic and fibrinolytic parameters

Haemophilia

Volumn 19, Issue 5, 2013, Pages 744-752

  Tuinenburg, A ^a   Biere Rafi, S ^b   Peters, M ^c   Verhamme, P ^d   Peerlinck, K ^d   Kruip, M J H A ^e   Laros Van Gorkom, B A P ^f   Roest, M ^g   Meijers, J C M ^b   Kamphuisen, P W ^b   Schutgens, R E G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c EMMA CHILDREN S HOSPITAL   (Netherlands)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^g UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Clotting factor concentrate; Coagulation; Fibrinolysis; Haemophilia; Obesity

Indexed keywords

ALPHA 2 ANTIPLASMIN; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR CONCENTRATE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN; THROMBIN; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD CLOTTING; BLOOD CLOTTING PARAMETERS; BODY MASS; CONTROLLED STUDY; DISEASE SEVERITY; FIBRINOLYSIS; HEMOPHILIA A; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

CLOTTING FACTOR CONCENTRATE; COAGULATION; FIBRINOLYSIS; HAEMOPHILIA; OBESITY;

BLOOD COAGULATION FACTORS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FIBRINOLYSIS; HEMOPHILIA A; HEMORRHAGE; HEMOSTASIS; HUMANS; MALE; MIDDLE AGED; OBESITY;

EID: 84883052144     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/hae.12182     Document Type: Article

References (25)

1. Berntorp E, Shapiro AD. Modern haemophilia care. Lancet 2012; 379: 1447-56.
2. Biggs R, Macfarlane RG. Haemophilia and related conditions: a survey of 187 cases. Br J Haematol 1958; 4: 1-27.
3. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010; 303: 235-41.
4. Hofstede FG, Fijnvandraat K, Plug I, Kamphuisen PW, Rosendaal FR, Peters M. Obesity: a new disaster for haemophilic patients? A nationwide survey Haemophilia 2008; 14: 1035-8.
5. Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 2009; 9: 88-108.
6. Soucie JM, Cianfrini C, Janco RL, Kulkarni R, Hambleton J, Evatt B et al. Joint range-of-motion limitations among young males with hemophilia: prevalence and risk factors. Blood 2004; 103: 2467-73.
7. Soucie JM, Wang C, Siddiqi A, Kulkarni R, Recht M, Konkle BA. The longitudinal effect of body adiposity on joint mobility in young males with Haemophilia A. Haemophilia 2011; 17: 196-203.
8. Faber DR, de Groot PG, Visseren FL. Role of adipose tissue in haemostasis, coagulation and fibrinolysis. Obes Rev 2009; 10: 554-63.
9. Mertens I, Van Gaal LF. Obesity, haemostasis and the fibrinolytic system. Obes Rev 2002; 3: 85-101.
10. Biere-Rafi S, Tuinenburg A, Haak BW, Peters M, Huijgen R, de GE et al. Factor VIII deficiency does not protect against atherosclerosis. J Thromb Haemost 2012; 10: 30-7.
11. Rendu R, Brohard-Bohn B. The platelet release reaction: granules' constituents, secretion and functions. Platelets 2001; 12: 261-73.
12. van Mourik JA, Boertjes R, Huisveld IA, Fijnvandraat K, Pajkrt D, van Genderen PJJ et al. von Willbrand factor propeptide in vascular disorders: a tool to distinguish between acute and chronic endothelial cell perturbation. Blood 1999; 94: 179-85.
13. Snoep JD, Roest M, Barendrecht AD, de Groot PG, Rosendaal FR, Van Der Bom JG. High platelet reactivity is associated with myocardial infarction in premenopausal women: a population-based case-control study. J Thromb Haemost 2010; 8: 906-13.
14. van Bladel ER, Roest M, de Groot PG, Schutgens RE. Up-regulation of platelet activation in hemophilia A. Haematologica 2011; 96: 888-95.
15. Hemker HC, Giesen P, Al DR, Regnault V, de SE, Wagenvoord R et al. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003; 33: 4-15.
16. Blann AD, Bushell D, Davies A, Faragher EB, Miller JP, McCollum CN. von Willebrand factor, the endothelium and obesity. Int J Obes Relat Metab Disord 1993; 17: 723-5.
17. Rosito GA, D'Agostino RB, Massaro J, Lipinska I, Mittleman MA, Sutherland P et al. Association between obesity and a prothrombotic state: the Framingham Offspring Study. Thromb Haemost 2004; 91: 683-9.
18. Koenig W. Fibrin(ogen) in cardiovascular disease: an update. Thromb Haemost 2003; 89: 601-9.
19. Eriksson P, Reynisdottir S, Lonnqvist F, Stemme V, Hamsten A, Arner P. Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals. Diabetologia 2011; 41: 65-71.
20. Samad F, Yamamoto K, Loskutoff DJ. Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo. Induction by tumor necrosis factor-alpha and lipopolysaccharide. J Clin Investig 1996; 97: 37-46.
21. Bajzar L, Morser J, Nesheim M. TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascade through the thrombin-thrombomoduling complex. J Biol Chem 1996; 271: 16603-8.
22. Broze GJ Jr, Higuchi DA. Coagulation-dependent inhibition of fibrinolysis: role of carboxypeptidase-U and the premature lysis of clots from hemophilic plasma. Blood 1996; 88: 3815-23.
23. Mosnier LO, Lisman T, van den Berg HM, Nieuwenhuis HK, Meijers JC, Bouma BN. The defective down regulation of fibrinolysis in haemophilia A can be restored by increasing the TAFI plasma concentration. Thromb Haemost 2001; 86: 1035-9.
24. Majumdar S, Ahmad N, Karlson C, Morris A, Iyer R. Does weight reduction in haemophilia lead to a decrease in joint bleeds? Haemophilia 2012; 18: e82-4.
25. Henrard S, Speybroeck N, Hermans C. Body weight and fat mass index as strong predictors of factor VIII in vivo recovery in adults with hemophilia A. J Thromb Haemost 2011; 9: 1784-90.